| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JA210751T |
| P698 | PubMed publication ID | 22280319 |
| P50 | author | Ludovico Sutto | Q57241335 |
| Leonardo Scapozza | Q58448519 | ||
| Francesco Luigi Gervasio | Q54665519 | ||
| Nicole Dölker | Q55163260 | ||
| P2093 | author name string | Silvia Lovera | |
| Ralitza Boubeva | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2496-2499 | |
| P577 | publication date | 2012-01-30 | |
| P1433 | published in | Journal of the American Chemical Society | Q898902 |
| P1476 | title | The different flexibility of c-Src and c-Abl kinases regulates the accessibility of a druggable inactive conformation | |
| P478 | volume | 134 |
| Q42046435 | A dynamically coupled allosteric network underlies binding cooperativity in Src kinase |
| Q35738216 | Activation pathway of Src kinase reveals intermediate states as targets for drug design |
| Q38800768 | Advanced molecular dynamics simulation methods for kinase drug discovery |
| Q38818757 | Changes in the free-energy landscape of p38α MAP kinase through its canonical activation and binding events as studied by enhanced molecular dynamics simulations |
| Q34408156 | Computational study of Gleevec and G6G reveals molecular determinants of kinase inhibitor selectivity |
| Q35043382 | Computational study of the "DFG-flip" conformational transition in c-Abl and c-Src tyrosine kinases |
| Q27704055 | Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity |
| Q41850714 | Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src. |
| Q36806236 | Conformational Selection and Induced Fit Mechanisms in the Binding of an Anticancer Drug to the c-Src Kinase |
| Q34045014 | Conformational Transition Pathways of Epidermal Growth Factor Receptor Kinase Domain from Multiple Molecular Dynamics Simulations and Bayesian Clustering |
| Q35493874 | Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors. |
| Q42359642 | Dynamic Equilibrium of the Aurora A Kinase Activation Loop Revealed by Single-Molecule Spectroscopy. |
| Q56889888 | Dynamics of human protein kinase Aurora A linked to drug selectivity |
| Q36967631 | Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase |
| Q34703677 | Energetic dissection of Gleevec's selectivity toward human tyrosine kinases. |
| Q48052175 | Energetics and structural characterization of the "DFG-flip" conformational transition of B-RAF kinase: a SITS molecular dynamics study |
| Q38998249 | Evolution and intelligent design in drug development |
| Q36582978 | Explaining why Gleevec is a specific and potent inhibitor of Abl kinase |
| Q35989696 | Heat dissipation guides activation in signaling proteins |
| Q93058867 | How Electrostatic Coupling Enables Conformational Plasticity in a Tyrosine Kinase |
| Q28553167 | Insight on Mutation-Induced Resistance from Molecular Dynamics Simulations of the Native and Mutated CSF-1R and KIT |
| Q27320874 | Investigating the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant |
| Q35509663 | Kinase dynamics. Using ancient protein kinases to unravel a modern cancer drug's mechanism |
| Q48296795 | Millisecond dynamics of BTK reveal kinome-wide conformational plasticity within the apo kinase domain. |
| Q28548366 | Molecular Determinants Underlying Binding Specificities of the ABL Kinase Inhibitors: Combining Alanine Scanning of Binding Hot Spots with Network Analysis of Residue Interactions and Coevolution |
| Q47662738 | Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity. |
| Q24338718 | Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling |
| Q38054133 | Molecular simulations of drug-receptor complexes in anticancer research |
| Q58465772 | New advances in metadynamics |
| Q54124846 | Predicting the Conformational Variability of Abl Tyrosine Kinase using Molecular Dynamics Simulations and Markov State Models. |
| Q47726053 | Remarkable Similarity in Plasmodium falciparum and Plasmodium vivax Geranylgeranyl Diphosphate Synthase (GGPPS) Dynamics and its Implication for Anti-Malarial Drug Design. |
| Q26785992 | Small Molecule Targeting of Protein-Protein Interactions through Allosteric Modulation of Dynamics |
| Q39277365 | Small-world networks of residue interactions in the Abl kinase complexes with cancer drugs: topology of allosteric communication pathways can determine drug resistance effects. |
| Q39724623 | Structural propensities of kinase family proteins from a Potts model of residue co-variation. |
| Q92934599 | Structure and Dynamics of the EGF Receptor as Revealed by Experiments and Simulations and Its Relevance to Non-Small Cell Lung Cancer |
| Q30008828 | The Activation of c-Src Tyrosine Kinase: Conformational Transition Pathway and Free Energy Landscape |
| Q35752926 | The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study |
| Q28543640 | The SH2 domain regulates c-Abl kinase activation by a cyclin-like mechanism and remodulation of the hinge motion |
| Q47794614 | The opening/closure of the P-loop and hinge of BCR-ABL1 decodes the low/high bioactivities of dasatinib and axitinib |
| Q28551159 | Towards a Molecular Understanding of the Link between Imatinib Resistance and Kinase Conformational Dynamics |
| Q36820157 | Transitions to catalytically inactive conformations in EGFR kinase |
| Q30008744 | Tyrosine Kinase Activation and Conformational Flexibility: Lessons from Src-Family Tyrosine Kinases. |
| Q34321892 | Virtual target screening: validation using kinase inhibitors |
Search more.